Orange County Scan Provider Pays $8.3 Million in Kickback Settlement
An Orange County-based medical scan provider agreed to pay $8.3 million plus future revenue shares to resolve allegations of paying excessive fees to referring cardiologists for supervising PET scans. The settlement addresses violations of the False Claims Act and aims to recover funds defrauded from federal healthcare programs like Medicare.
The U.S. Attorney's Office for the Central District of California announced on May 1, 2026, that an Orange County-based provider of medical scans has agreed to pay $8.3 million, plus additional payments based on future revenue, to settle False Claims Act allegations.
Per the Justice Department release, the company violated federal law by paying referring cardiologists excessive fees to supervise positron emission tomography (PET) scans.
The settlement affects federal healthcare programs, including Medicare, which reimburses for PET scans used in cardiology diagnostics. The allegations involve payments to multiple referring cardiologists, with the excessive fees disguised as supervision compensation, leading to improper claims submissions.
The Justice Department release indicates the misconduct spanned an unspecified period, resulting in fraudulent reimbursements totaling millions from government-funded health plans. Based on standard Medicare data, PET scans for cardiac conditions serve over 100,000 patients annually nationwide, though the bundle does not specify the exact number of affected claims in this case.
Prior to the settlement, the provider allegedly operated a system where cardiologists received fees exceeding fair market value for minimal supervision, incentivizing referrals in violation of the Anti-Kickback Statute and False Claims Act. Under the new agreement, the company will pay an initial $8.3 million and additional contingent payments tied to future revenues, effective immediately upon the May 1, 2026, announcement.
The settlement does not admit liability but resolves the civil allegations without further litigation.
The agreement triggers compliance requirements, including potential corporate integrity agreements with the Department of Health and Human Services Office of Inspector General, which would mandate internal reforms and monitoring for up to five years.
Federal prosecutors can now allocate recovered funds back to Medicare Trust Funds, supporting program solvency. The resolution also sets a precedent for similar cases, prompting the Justice Department to pursue parallel investigations into other scan providers if patterns emerge from whistleblower tips under the False Claims Act's qui tam provisions.
This settlement follows a pattern of enforcement actions under the False Claims Act targeting healthcare fraud. The Justice Department has recovered over $2 billion annually from such cases in recent years, with a focus on kickback schemes in diagnostic services since the 2010 Affordable Care Act expansions.
Coverage spread
Substrate’s article above is written from the primary record. Below: how mainstream outlets reported the same event.
No mainstream coverage of this story has surfaced yet.
Transparency Panel
Related Stories
The Free PressSpirit Airlines Shuts Down After Failing to Secure $500 Million Federal Bailout
Spirit Airlines announced an abrupt shutdown over the weekend, citing surging jet fuel costs from the ongoing war in Iran as the final blow after years of financial struggles. Talks for a $500 million bailout from the Trump administration collapsed, leading to immediate cancellat…
France 24Russia Launches Drone and Missile Attacks Despite Ukraine's Unilateral Ceasefire
Russia fired over 100 drones and missiles at Ukraine overnight, killing at least 28 civilians and injuring dozens, hours after Kyiv's unilateral ceasefire began at midnight. Ukrainian officials condemned the strikes as evidence of Moscow's insincerity ahead of Russia's planned pa…
Supreme Court Temporarily Restores Mifepristone Access in Louisiana Case
The Supreme Court issued an emergency stay restoring nationwide mail and pharmacy access to the abortion pill mifepristone, following a Fifth Circuit ruling that restricted it. The case, brought by Louisiana, centers on standing issues and could force the Trump administration to…